Rhamnetin as an inhibitor of SIRT1, enhances miR-148a transcription thus inhibits PXR/CYP3A4/MDR1 signal, slowing down the metabolic detoxification of sorafenib in HCC cells and enhancing the sensitivity of HCC cells to sorafenib 127. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.